OpenBilldrug price receipt

NADAC week of 2026-10-14

MUCUS RLF DM MAX ER 1200-60 MG

FDA nonproprietary name: guaifenesin, dextromethorphan hbr

For 30 tablets

Pharmacies pay

$16.34 filed

30 × $0.54461 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$23.79 estimated

$16.34 + $2.45 (15%) + $5.00 fee per fill = $23.79

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

MUCUS RLF DM MAX ER 1200-60 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “guaifenesin, dextromethorphan hbr” and “dextromethorphan hydrobromide, guaifenesin”, as its NDCs’ listings variously write the nonproprietary name, under the trade names “Mucus Relief DM Extended Release Caplets” and “RUGBY MUCUS RELIEF DM ER”.

FDA gives its dosage form as “tablet, extended release” and “tablet” and its route as oral.

Its labelers, the companies named on the label, are Rugby Laboratories and Cardinal Health (Leader) 70000.

FDA lists it under 3 Established Pharmacologic Classes: Expectorant, Sigma-1 Agonist and Uncompetitive N-methyl-D-aspartate Receptor Antagonist.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and marks it as sold over the counter.

What pharmacies pay

Pharmacies pay $16.34 for 30 tablets (30 × $0.54461 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 3 NDCs

Other strengths, forms and brands

12 other products in the NADAC file share an FDA nonproprietary name with MUCUS RLF DM MAX ER 1200-60 MG.

ProductPharmacies pay per unitMedicare per unit
CHEST CONGESTION RELIEF DM SYR
generic · liquid
$0.00905 per ML filed
eff. 2026-09-23
We don’t know yet
COUGH DM 20-200 MG/20 ML SYRUP
generic · solution
$0.01683 per ML filed
eff. 2026-09-23
We don’t know yet
FT MUCUS DM ER 600-30 MG TAB
generic · tablet, extended release
$0.35604 per EA filed
eff. 2026-09-23
We don’t know yet
FT MUCUS DM MAX ER 1200-60 MG
generic · tablet, extended release
$0.54461 per EA filed
eff. 2026-09-23
We don’t know yet
FT TUSSIN DM 200-20 MG/20 ML
generic · solution
$0.01477 to $0.02069 per ML filed
eff. 2026-09-23
We don’t know yet
GNP MUCUS DM ER 600-30 MG TAB
generic · tablet, extended release
$0.35604 per EA filed
eff. 2026-09-23
We don’t know yet
GNP TUSSIN DM 200-20 MG/20 ML
generic · solution
$0.01477 to $0.02069 per ML filed
eff. 2026-09-23
We don’t know yet
GNP TUSSIN DM MAX LIQUID
generic · solution
$0.01778 per ML filed
eff. 2026-09-23
We don’t know yet
GS TUSSIN DM 200-20 MG/20 ML
generic · solution
$0.01477 to $0.02069 per ML filed
eff. 2026-09-23
We don’t know yet
MUCOLYTE-DM 100-10 MG/5 ML LIQ
generic · liquid
$0.01105 per ML filed
eff. 2026-09-23
We don’t know yet
MUCUS RLF DM ER 600-30 MG TAB
generic · tablet, extended release
$0.35604 per EA filed
eff. 2026-09-23
We don’t know yet
MUCUS RLF DM MAX ER 1200-60 MG this page
generic · tablet, extended release / tablet
$0.54461 per EA filed
eff. 2026-09-23
We don’t know yet
ROBAFEN DM 200-20 MG/20 ML LIQ
generic · solution
$0.01477 to $0.02069 per ML filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $0.54461 per EA filed.

Of the 68 other products in FDA’s Expectorant class priced per EA, 2 have a higher middle NADAC price and 61 a lower one; 5 have the same. The one in the middle is QC MUCUS RLF COLD-FLU-THRT CPT, at $0.13211 per EA filed (eff. 2026-09-23).

Of the 46 other products in FDA’s Sigma-1 Agonist class priced per EA, 4 have a higher middle NADAC price and 37 a lower one; 5 have the same. The one in the middle is DAYTIME COLD-FLU RELIEF SFTGL, at $0.13116 per EA filed (eff. 2026-09-23).

Of the 46 other products in FDA’s Uncompetitive N-methyl-D-aspartate Receptor Antagonist class priced per EA, 4 have a higher middle NADAC price and 37 a lower one; 5 have the same. The one in the middle is DAYTIME COLD-FLU RELIEF SFTGL, at $0.13116 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.